Albertsons Companies

ACI

Market cap $9.1B

Albertsons Companies trades at a discounted 8.0x P/E, offering a 3.5% dividend yield and robust value for dividend investors. ACI demonstrates steady identical sales growth, strong pharmacy momentum, and expanding digital engagement. AI-driven personalization and efficiency initiatives are yielding early benefits, including a 10% increase in basket size and improved customer retention.

Albertsons Companies NYSE: ACI presents a compelling value proposition in 2026, but the question is whether it is an opportunity for investors, and the signs suggest it is. While price action is bearish, results are outperforming expectations, and stock accumulation is underway.

Albertsons shares fall 6% after Q3 results, as earnings beat and sales growth are overshadowed by margin pressure and pricing investments.

Market Catalysts anchor Julie Hyman breaks down the latest market moves for January 8, 2026. Senior reporter Brooke DiPalma breaks down Wall Street's top calls, including Alphabet, Gap, and Albertsons.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Albertsons Companies (ACI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Although the revenue and EPS for Albertsons Companies (ACI) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Albertsons Companies, Inc. (ACI) Q3 2026 Earnings Call Transcript

Albertsons Companies is seeing early results of its deeper integration of data and artificial intelligence, and the firm expects these resources to serve as the core of its transformation efforts, executives said Wednesday (Jan. 7) during an earnings call.

Albertons reported higher third-quarter sales on the back of growth in its pharmacy and digital businesses.